15
Previously on Bio308 Graves’ Disease data activating and negative feedback loops are ‘fine’ Therefore: Hypothesis 1 not supported Not an extracellular signaling problem Move to Hypothesis 2: Cell Interpreting Signal Incorrectly Background on Receptor Activation *What does it takes to be in a membrane and to be a receptor

Previously on Bio308

  • Upload
    kaden

  • View
    29

  • Download
    0

Embed Size (px)

DESCRIPTION

Previously on Bio308. Graves’ Disease data activating and negative feedback loops are ‘fine’ Therefore: Hypothesis 1 not supported Not an extracellular signaling problem Move to Hypothesis 2: Cell Interpreting Signal Incorrectly Background on Receptor Activation - PowerPoint PPT Presentation

Citation preview

Page 1: Previously on Bio308

Previously on Bio308Graves’ Disease data

activating and negative feedback loops are ‘fine’ Therefore: Hypothesis 1 not supported

Not an extracellular signaling problem

Move to Hypothesis 2: Cell Interpreting Signal IncorrectlyBackground on Receptor Activation*What does it takes to be in a membrane

and to be a receptor

Page 2: Previously on Bio308

Other mechanisms that regulate protein function

•Compartmentalization•Change in rate of synthesis

Common traits?

•Cleavage•Phosphorylation/dephosphorylation

Common traits?

Page 3: Previously on Bio308

Receptor’s role (summary)Able to transduce signal because of:

•Placement in membrane (span it)•Ability to bind ligand•Ligand -induced conformational changes

So the signal ‘gets in’ without physically crossing membrane

BUT How do you go from a shape change to causing a change in gene expression?

Page 4: Previously on Bio308

Surface toNucleus:Types of signaling proteins

MBoC4 Fig15-16

Page 5: Previously on Bio308

Thyroid

What is constitutive activity?

Page 6: Previously on Bio308

Cascade examples

Page 7: Previously on Bio308

(not trimeric) G protein switch

Note the dramatic shape change depending upon thebinding partner(s)

Page 8: Previously on Bio308

cAMP 2nd messenger

Page 9: Previously on Bio308

Other 2nd messengers

Page 10: Previously on Bio308

cAMP dep. Protein Kinase

Page 11: Previously on Bio308

After activation

Page 12: Previously on Bio308

Transcriptional activation

Page 13: Previously on Bio308

Others

Your summaries go here

Page 14: Previously on Bio308

On to Off

Hyper activity is the problem in Graves’ disease-- What ‘should’ happen to each component of the

cascade to make the cascade turn off?

Page 15: Previously on Bio308

BUT Internal signaling in Graves’ Patients is fine…

There goes another perfectly good hypothesis, rejected due to data.

Next on Bio 308 (class cancelled on Thurs. Use time to catch up)

Graves’ disease: Comparing information from other situationsand disease specific information to come up withanother hypothesis for the molecular basis of this disease

CausesHow does it all add up?

TreatmentsIntroduction to paper discussion: